Tumor recurrence after complete resection for non-small cell lung cancer
- PMID: 22542070
- DOI: 10.1016/j.athoracsur.2012.03.031
Tumor recurrence after complete resection for non-small cell lung cancer
Abstract
Background: Long-term survival after R0 resection for non-small cell lung cancer (NSCLC) is less than 50%. The majority of mortality after resection is related to tumor recurrence. The purpose of this study was to identify independent perioperative and pathologic variables that are associated with NSCLC recurrence after complete surgical resection.
Methods: A retrospective examination was performed of a prospectively maintained database of patients who underwent resection for NSCLC from July 1999 to August 2008 at a single institution. Clinicopathologic variables were evaluated for their influence on time to recurrence. Cox's proportional regression hazard model examined the association of recurrence in NSCLC.
Results: A total of 1,143 patients met inclusion criteria and had complete follow-up information. Of these patients, 378 (33.1%) had recurrence of the primary cancer. Median follow-up was 24 months (range, 3-134 months). Preoperative tumor maximum standardized uptake value (SUVmax) greater than 5 was associated with increased risk of recurrence (hazard ratio [HR], 1.81; p=0.01). Preoperative radiation was independently associated with recurrence (HR, 1.98; p=0.05) as well as the presence of pathologic stage II and stage III disease (stage II: HR, 2.53; p=0.05; stage III: HR, 6.49; p=0.006). Subgroup analysis found that sublobar resection was also associated with locoregional recurrence after resection (HR, 4.17; p=0.02) and lymphovascular invasion of distant recurrence (HR, 4.21; p=0.002).
Conclusions: In the largest series reported to date on postresectional recurrence of NSCLC, SUVmax greater than 5, increasing pathologic stage, and the administration of preoperative radiation were independently associated with NSCLC recurrence after resection. Sublobar resection was independently associated with locoregional recurrence, and lymphovascular invasion was associated with distant recurrence.
Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.J Thorac Cardiovasc Surg. 2013 Aug;146(2):372-8. doi: 10.1016/j.jtcvs.2013.02.057. J Thorac Cardiovasc Surg. 2013. PMID: 23870323
-
Prognostic predictors in non-small cell lung cancer patients undergoing intentional segmentectomy.Ann Thorac Surg. 2012 Jun;93(6):1788-94. doi: 10.1016/j.athoracsur.2012.02.093. Epub 2012 May 3. Ann Thorac Surg. 2012. PMID: 22560265
-
Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections.Eur J Cardiothorac Surg. 2008 Apr;33(4):728-34. doi: 10.1016/j.ejcts.2007.12.048. Epub 2008 Feb 7. Eur J Cardiothorac Surg. 2008. PMID: 18261918
-
Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.Ann Thorac Surg. 2004 Oct;78(4):1200-5; discussion 1206. doi: 10.1016/j.athoracsur.2004.04.085. Ann Thorac Surg. 2004. PMID: 15464470 Review.
-
Anatomic segmentectomy and brachytherapy mesh implantation for clinical stage I non-small cell lung cancer (NSCLC).Surgery. 2014 Feb;155(2):340-6. doi: 10.1016/j.surg.2013.06.055. Epub 2013 Dec 5. Surgery. 2014. PMID: 24314884 Review.
Cited by
-
Possible role of circulating tumor cells in early detection of lung cancer.J Thorac Dis. 2020 Jul;12(7):3821-3835. doi: 10.21037/jtd.2020.02.24. J Thorac Dis. 2020. PMID: 32802464 Free PMC article. Review.
-
Efficacy, safety, and survival of neoadjuvant immunochemotherapy in operable non-small cell lung cancer: a systematic review and meta-analysis.Front Immunol. 2023 Dec 1;14:1273220. doi: 10.3389/fimmu.2023.1273220. eCollection 2023. Front Immunol. 2023. PMID: 38106421 Free PMC article.
-
Incidence and clinical relevance of non-small cell lung cancer lymph node micro-metastasis detected by staging endobronchial ultrasound-guided transbronchial needle aspiration.J Thorac Dis. 2019 Aug;11(8):3650-3658. doi: 10.21037/jtd.2019.05.36. J Thorac Dis. 2019. PMID: 31559073 Free PMC article.
-
Liquid Biopsy in Early-Stage Lung Cancer: Current and Future Clinical Applications.Cancers (Basel). 2023 May 10;15(10):2702. doi: 10.3390/cancers15102702. Cancers (Basel). 2023. PMID: 37345038 Free PMC article. Review.
-
Definitive Radiotherapy for Local Recurrence of NSCLC After Surgery.Clin Lung Cancer. 2017 May;18(3):e161-e168. doi: 10.1016/j.cllc.2017.01.014. Epub 2017 Feb 21. Clin Lung Cancer. 2017. PMID: 28302437 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous